IRB Number:

1849-03

Trial Status:

Open for Enrollment

Phase: II

Why is this study being done?

The study evaluates minimally invasive and highly sensitive molecular methods to detect early cancer spread to lymph nodes. Lymph nodes are sampled with endoscopy and ultrasound-guided biopsy, then evaluated for genes associated with cancer spread.

Who is Eligible to Participate in the Study?

Adult patients with newly diagnosed or suspected lung cancer. Patients cannot have had other cancers within five years.

Minimum Age:

18

Maximum Age:

100

What is Involved With this Study?

Patients with lung tumors will undergo routine tests to determine if the tumor is cancerous, and if so, if it has spread. These tests include CAT scans, PET scans and endoscopic ultrasound. At the time of endoscopic ultrasound, routine biopsies of lymph nodes are taken. For research purposes, one extra sample will be obtained for tests to look for cancer-associated genes.

How long will the Study run?

5 years

Who can I Contact for Additional Information on this Trial?

Complete Request Form for Cancer Clinical Trial Information at Mayo Clinic or
Joy Hardee, CCRN (study coordinator)
Michael Wallace, MD MPH (principal investigator)
(904) 953-8456

What is/are the Locations of this Clinical Trial?

• Jacksonville, FL

Last updated: 08/22/2006